During a panel session at the recent LSX World Congress industry spectators discussed the state of biopharma investing and how companies can prepare now for the return of the public markets.
“While the public markets are pretty depressed, we have the great fortune to be in an environment where pharmaceutical companies...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?